▶ 調査レポート

皮膚充填剤・ボツリヌス毒素のグローバル販売市場 2020年

• 英文タイトル:Global Dermal Fillers and Botulinum Toxin Sales Market Report 2020
• レポートコード:MRC2102QY3995
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、147ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥552,000 (USD4,000)▷ お問い合わせ
  Multi User¥828,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,104,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の皮膚充填剤・ボツリヌス毒素市場について種類別(皮膚充填剤、ボツリヌス毒素)、用途別(医療、化粧品)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・皮膚充填剤・ボツリヌス毒素市場の概要
・世界の主要地域別皮膚充填剤・ボツリヌス毒素市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の皮膚充填剤・ボツリヌス毒素市場規模2015-2026:種類別(皮膚充填剤、ボツリヌス毒素)
・世界の皮膚充填剤・ボツリヌス毒素市場規模2015-2026:用途別(医療、化粧品)
・皮膚充填剤・ボツリヌス毒素の米国市場規模2015-2020
・皮膚充填剤・ボツリヌス毒素のヨーロッパ市場規模2015-2020
・皮膚充填剤・ボツリヌス毒素の中国市場規模2015-2020
・皮膚充填剤・ボツリヌス毒素の日本市場規模2015-2020
・皮膚充填剤・ボツリヌス毒素の東南アジア市場規模2015-2020
・皮膚充填剤・ボツリヌス毒素のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・皮膚充填剤・ボツリヌス毒素の製造コスト分析
・販売チャネル、流通業者、顧客
・皮膚充填剤・ボツリヌス毒素の市場動向・機会・課題
・調査の結論

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.
Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.

Market Analysis and Insights: Global Dermal Fillers and Botulinum Toxin Market
The global Dermal Fillers and Botulinum Toxin market size is projected to reach US$ 23400 million by 2026, from US$ 10550 million in 2020, at a CAGR of 14.2% during 2021-2026.

Global Dermal Fillers and Botulinum Toxin Scope and Market Size
The global Dermal Fillers and Botulinum Toxin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermal Fillers and Botulinum Toxin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Dermal Fillers and Botulinum Toxin market is segmented into
Dermal Fillers
Botulinum Toxin
The proportion of dermal fillers in 2019 is about 52%.

Segment by Application, the Dermal Fillers and Botulinum Toxin market is segmented into
Medical
Cosmetic
The most of dermal fillers and botulinum toxin is used in cosmetic, and the market share of that is about 75.5% in 2019.

The Dermal Fillers and Botulinum Toxin market is analysed and market size information is provided by regions (countries). Segment by Application, the Dermal Fillers and Botulinum Toxin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Dermal Fillers and Botulinum Toxin Market Share Analysis
Dermal Fillers and Botulinum Toxin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dermal Fillers and Botulinum Toxin business, the date to enter into the Dermal Fillers and Botulinum Toxin market, Dermal Fillers and Botulinum Toxin product introduction, recent developments, etc.

The major vendors covered:
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong

レポート目次

1 Dermal Fillers and Botulinum Toxin Market Overview
1.1 Dermal Fillers and Botulinum Toxin Product Scope
1.2 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2020-2026)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.3 Dermal Fillers and Botulinum Toxin Segment by Application
1.3.1 Global Dermal Fillers and Botulinum Toxin Sales Comparison by Application (2020-2026)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dermal Fillers and Botulinum Toxin Sales Growth Rate (2015-2026)
1.4.2 Global Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2015-2026)
1.4.3 Global Dermal Fillers and Botulinum Toxin Price Trends (2015-2026)

2 Dermal Fillers and Botulinum Toxin Estimate and Forecast by Region
2.1 Global Dermal Fillers and Botulinum Toxin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2015-2020)
2.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2015-2020)
2.3 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dermal Fillers and Botulinum Toxin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
2.4.2 Europe Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
2.4.3 China Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
2.4.4 Japan Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
2.4.6 India Dermal Fillers and Botulinum Toxin Estimates and Projections (2015-2026)
3 Global Dermal Fillers and Botulinum Toxin Competition Landscape by Players
3.1 Global Top Dermal Fillers and Botulinum Toxin Players by Sales (2015-2020)
3.2 Global Top Dermal Fillers and Botulinum Toxin Players by Revenue (2015-2020)
3.3 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2019)
3.4 Global Dermal Fillers and Botulinum Toxin Average Price by Company (2015-2020)
3.5 Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dermal Fillers and Botulinum Toxin Players (Opinion Leaders)
4 Global Dermal Fillers and Botulinum Toxin Market Size by Type
4.1 Global Dermal Fillers and Botulinum Toxin Historic Market Review by Type (2015-2020)
4.1.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
4.1.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2015-2020)
4.1.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2015-2020)
4.2 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2021-2026)
4.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2021-2026)
4.2.3 Global Dermal Fillers and Botulinum Toxin Price Forecast by Type (2021-2026)
5 Global Dermal Fillers and Botulinum Toxin Market Size by Application
5.1 Global Dermal Fillers and Botulinum Toxin Historic Market Review by Application (2015-2020)
5.1.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
5.1.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2015-2020)
5.1.3 Global Dermal Fillers and Botulinum Toxin Price by Application (2015-2020)
5.2 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2021-2026)
5.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2021-2026)

6 United States Dermal Fillers and Botulinum Toxin Market Facts & Figures
6.1 United States Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
6.2 United States Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
6.3 United States Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

7 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures
7.1 Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
7.2 Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
7.3 Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

8 China Dermal Fillers and Botulinum Toxin Market Facts & Figures
8.1 China Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
8.2 China Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
8.3 China Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

9 Japan Dermal Fillers and Botulinum Toxin Market Facts & Figures
9.1 Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Company (3015-3030)
9.2 Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
9.3 Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

10 Southeast Asia Dermal Fillers and Botulinum Toxin Market Facts & Figures
10.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

11 India Dermal Fillers and Botulinum Toxin Market Facts & Figures
11.1 India Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
11.2 India Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
11.3 India Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Dermal Fillers and Botulinum Toxin Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Dermal Fillers and Botulinum Toxin Products Offered
12.1.5 Allergan Recent Development
12.2 Galderma
12.2.1 Galderma Corporation Information
12.2.2 Galderma Business Overview
12.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Galderma Dermal Fillers and Botulinum Toxin Products Offered
12.2.5 Galderma Recent Development
12.3 LG Life Science
12.3.1 LG Life Science Corporation Information
12.3.2 LG Life Science Business Overview
12.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Products Offered
12.3.5 LG Life Science Recent Development
12.4 Merz
12.4.1 Merz Corporation Information
12.4.2 Merz Business Overview
12.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merz Dermal Fillers and Botulinum Toxin Products Offered
12.4.5 Merz Recent Development
12.5 Medytox
12.5.1 Medytox Corporation Information
12.5.2 Medytox Business Overview
12.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medytox Dermal Fillers and Botulinum Toxin Products Offered
12.5.5 Medytox Recent Development
12.6 Bloomage
12.6.1 Bloomage Corporation Information
12.6.2 Bloomage Business Overview
12.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bloomage Dermal Fillers and Botulinum Toxin Products Offered
12.6.5 Bloomage Recent Development
12.7 Bohus BioTech
12.7.1 Bohus BioTech Corporation Information
12.7.2 Bohus BioTech Business Overview
12.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Products Offered
12.7.5 Bohus BioTech Recent Development
12.8 Sinclair Pharma
12.8.1 Sinclair Pharma Corporation Information
12.8.2 Sinclair Pharma Business Overview
12.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Products Offered
12.8.5 Sinclair Pharma Recent Development
12.9 IMEIK
12.9.1 IMEIK Corporation Information
12.9.2 IMEIK Business Overview
12.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 IMEIK Dermal Fillers and Botulinum Toxin Products Offered
12.9.5 IMEIK Recent Development
12.10 Suneva Medical
12.10.1 Suneva Medical Corporation Information
12.10.2 Suneva Medical Business Overview
12.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Products Offered
12.10.5 Suneva Medical Recent Development
12.11 Teoxane
12.11.1 Teoxane Corporation Information
12.11.2 Teoxane Business Overview
12.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Teoxane Dermal Fillers and Botulinum Toxin Products Offered
12.11.5 Teoxane Recent Development
12.12 Luminera
12.12.1 Luminera Corporation Information
12.12.2 Luminera Business Overview
12.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Luminera Dermal Fillers and Botulinum Toxin Products Offered
12.12.5 Luminera Recent Development
12.13 SciVision Biotech
12.13.1 SciVision Biotech Corporation Information
12.13.2 SciVision Biotech Business Overview
12.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Products Offered
12.13.5 SciVision Biotech Recent Development
12.14 Haohai Bio
12.14.1 Haohai Bio Corporation Information
12.14.2 Haohai Bio Business Overview
12.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Haohai Bio Dermal Fillers and Botulinum Toxin Products Offered
12.14.5 Haohai Bio Recent Development
12.15 Ipsen
12.15.1 Ipsen Corporation Information
12.15.2 Ipsen Business Overview
12.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ipsen Dermal Fillers and Botulinum Toxin Products Offered
12.15.5 Ipsen Recent Development
12.16 LIBP
12.16.1 LIBP Corporation Information
12.16.2 LIBP Business Overview
12.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.16.4 LIBP Dermal Fillers and Botulinum Toxin Products Offered
12.16.5 LIBP Recent Development
12.17 US World Meds
12.17.1 US World Meds Corporation Information
12.17.2 US World Meds Business Overview
12.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.17.4 US World Meds Dermal Fillers and Botulinum Toxin Products Offered
12.17.5 US World Meds Recent Development
12.18 Hugel
12.18.1 Hugel Corporation Information
12.18.2 Hugel Business Overview
12.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Hugel Dermal Fillers and Botulinum Toxin Products Offered
12.18.5 Hugel Recent Development
12.19 Daewoong
12.19.1 Daewoong Corporation Information
12.19.2 Daewoong Business Overview
12.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Daewoong Dermal Fillers and Botulinum Toxin Products Offered
12.19.5 Daewoong Recent Development

13 Dermal Fillers and Botulinum Toxin Manufacturing Cost Analysis
13.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
13.4 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermal Fillers and Botulinum Toxin Distributors List
14.3 Dermal Fillers and Botulinum Toxin Customers

15 Market Dynamics
15.1 Dermal Fillers and Botulinum Toxin Market Trends
15.2 Dermal Fillers and Botulinum Toxin Opportunities and Drivers
15.3 Dermal Fillers and Botulinum Toxin Market Challenges
15.4 Dermal Fillers and Botulinum Toxin Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Dermal Fillers and Botulinum Toxin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Region (2015-2020)
Table 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2015-2020)
Table 6. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Dermal Fillers and Botulinum Toxin Revenue Share by Region (2015-2020)
Table 8. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Dermal Fillers and Botulinum Toxin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Dermal Fillers and Botulinum Toxin (K Units) of Key Companies (2015-2020)
Table 13. Global Dermal Fillers and Botulinum Toxin Sales Share by Company (2015-2020)
Table 14. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Dermal Fillers and Botulinum Toxin Revenue Share by Company (2015-2020)
Table 16. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2019)
Table 17. Global Dermal Fillers and Botulinum Toxin Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites and Area Served
Table 19. Manufacturers Dermal Fillers and Botulinum Toxin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Dermal Fillers and Botulinum Toxin Players
Table 22. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 23. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2015-2020)
Table 24. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Dermal Fillers and Botulinum Toxin Price (K Units) by Type (2015-2020)
Table 26. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2021-2026)
Table 27. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2021-2026)
Table 29. Global Dermal Fillers and Botulinum Toxin Price (K Units) by Type (2021-2026)
Table 30. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 31. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2015-2020)
Table 32. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Dermal Fillers and Botulinum Toxin Price (K Units) by Application (2015-2020)
Table 34. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2021-2026)
Table 35. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2021-2026)
Table 36. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2021-2026)
Table 38. Global Dermal Fillers and Botulinum Toxin Price (K Units) by Application (2021-2026)
Table 39. United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 40. United States Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 41. United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 42. United States Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 43. United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 44. United States Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
Table 45. Europe Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 46. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 47. Europe Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 48. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 49. Europe Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 50. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 51. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 52. China Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 53. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 54. China Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 55. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 56. China Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
Table 57. Japan Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 58. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 59. Japan Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 60. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 61. Japan Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 62. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
Table 69. India Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2015-2020)
Table 70. India Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2015-2020)
Table 71. India Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2015-2020)
Table 72. India Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2015-2020)
Table 73. India Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2015-2020)
Table 74. India Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2015-2020)
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Allergan Dermal Fillers and Botulinum Toxin Product
Table 79. Allergan Recent Development
Table 80. Galderma Corporation Information
Table 81. Galderma Description and Business Overview
Table 82. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Galderma Dermal Fillers and Botulinum Toxin Product
Table 84. Galderma Recent Development
Table 85. LG Life Science Corporation Information
Table 86. LG Life Science Description and Business Overview
Table 87. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. LG Life Science Dermal Fillers and Botulinum Toxin Product
Table 89. LG Life Science Recent Development
Table 90. Merz Corporation Information
Table 91. Merz Description and Business Overview
Table 92. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Merz Dermal Fillers and Botulinum Toxin Product
Table 94. Merz Recent Development
Table 95. Medytox Corporation Information
Table 96. Medytox Description and Business Overview
Table 97. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Medytox Dermal Fillers and Botulinum Toxin Product
Table 99. Medytox Recent Development
Table 100. Bloomage Corporation Information
Table 101. Bloomage Description and Business Overview
Table 102. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. Bloomage Dermal Fillers and Botulinum Toxin Product
Table 104. Bloomage Recent Development
Table 105. Bohus BioTech Corporation Information
Table 106. Bohus BioTech Description and Business Overview
Table 107. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 108. Bohus BioTech Dermal Fillers and Botulinum Toxin Product
Table 109. Bohus BioTech Recent Development
Table 110. Sinclair Pharma Corporation Information
Table 111. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Sinclair Pharma Description and Business Overview
Table 113. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product
Table 114. Sinclair Pharma Recent Development
Table 115. IMEIK Corporation Information
Table 116. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. IMEIK Description and Business Overview
Table 118. IMEIK Dermal Fillers and Botulinum Toxin Product
Table 119. IMEIK Recent Development
Table 120. Suneva Medical Corporation Information
Table 121. Suneva Medical Description and Business Overview
Table 122. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 123. Suneva Medical Dermal Fillers and Botulinum Toxin Product
Table 124. Suneva Medical Recent Development
Table 125. Teoxane Corporation Information
Table 126. Teoxane Description and Business Overview
Table 127. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 128. Teoxane Dermal Fillers and Botulinum Toxin Product
Table 129. Teoxane Recent Development
Table 130. Luminera Corporation Information
Table 131. Luminera Description and Business Overview
Table 132. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 133. Luminera Dermal Fillers and Botulinum Toxin Product
Table 134. Luminera Recent Development
Table 135. SciVision Biotech Corporation Information
Table 136. SciVision Biotech Description and Business Overview
Table 137. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 138. SciVision Biotech Dermal Fillers and Botulinum Toxin Product
Table 139. SciVision Biotech Recent Development
Table 140. Haohai Bio Corporation Information
Table 141. Haohai Bio Description and Business Overview
Table 142. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 143. Haohai Bio Dermal Fillers and Botulinum Toxin Product
Table 144. Haohai Bio Recent Development
Table 145. Ipsen Corporation Information
Table 146. Ipsen Description and Business Overview
Table 147. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 148. Ipsen Dermal Fillers and Botulinum Toxin Product
Table 149. Ipsen Recent Development
Table 150. LIBP Corporation Information
Table 151. LIBP Description and Business Overview
Table 152. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 153. LIBP Dermal Fillers and Botulinum Toxin Product
Table 154. LIBP Recent Development
Table 155. US World Meds Corporation Information
Table 156. US World Meds Description and Business Overview
Table 157. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 158. US World Meds Dermal Fillers and Botulinum Toxin Product
Table 159. US World Meds Recent Development
Table 160. Hugel Corporation Information
Table 161. Hugel Description and Business Overview
Table 162. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 163. Hugel Dermal Fillers and Botulinum Toxin Product
Table 164. Hugel Recent Development
Table 165. Daewoong Corporation Information
Table 166. Daewoong Description and Business Overview
Table 167. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 168. Daewoong Dermal Fillers and Botulinum Toxin Product
Table 169. Daewoong Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Dermal Fillers and Botulinum Toxin Distributors List
Table 173. Dermal Fillers and Botulinum Toxin Customers List
Table 174. Dermal Fillers and Botulinum Toxin Market Key Trends
Table 175. Dermal Fillers and Botulinum Toxin Key Opportunities and Drivers
Table 176. Dermal Fillers and Botulinum Toxin Market Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Fillers and Botulinum Toxin Product Picture
Figure 2. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Market Share by Application in 2020 & 2026
Figure 6. Medical Examples
Figure 7. Cosmetic Examples
Figure 8. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Dermal Fillers and Botulinum Toxin Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 11. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Dermal Fillers and Botulinum Toxin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Dermal Fillers and Botulinum Toxin Players Market Share by Revenue in Dermal Fillers and Botulinum Toxin 2015 & 2019
Figure 26. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2015-2020)
Figure 28. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2015-2020)
Figure 30. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 32. United States Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 33. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Company in 2019
Figure 34. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 35. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2019
Figure 36. China Dermal Fillers and Botulinum Toxin Sales Market Share by Company in 2019
Figure 37. China Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 38. China Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2019
Figure 39. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Company in 2019
Figure 40. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 41. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2019
Figure 45. India Dermal Fillers and Botulinum Toxin Sales Market Share by Company in 2019
Figure 46. India Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2019
Figure 47. India Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Dermal Fillers and Botulinum Toxin
Figure 50. Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
Figure 51. Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed



• 英文レポート名:Global Dermal Fillers and Botulinum Toxin Sales Market Report 2020
• 日本語訳:皮膚充填剤・ボツリヌス毒素のグローバル販売市場 2020年
• レポートコード:MRC2102QY3995お問い合わせ(見積依頼・ご注文・質問)